We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

130 hedge funds and large institutions have $316M invested in Sciclone Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more call options, than puts

Call options by funds: $247K | Put options by funds: $47K

54% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 131 → 130 (-1)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

52% less capital invested

Capital invested by funds: $652M → $316M (-$336M)

Holders
130
Holders Change
-1
Holders Change %
-0.76%
% of All Funds
3.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
54
Reduced
35
Closed
17
Calls
$247K
Puts
$47K
Net Calls
+$200K
Net Calls Change
+$531K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$2.47M
2
Millennium Management
Millennium Management
New York
+$2.02M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.92M
4
GCP
GSA Capital Partners
United Kingdom
+$1.47M
5
SI
Sensato Investors
California
+$1.37M

Top Sellers

Rank Fund Capital Flow
1
ACM
Americafirst Capital Management
California
-$351M
2
BIM
Bogle Investment Management
Massachusetts
-$2.52M
3
MCM
McKinley Capital Management
Alaska
-$2.43M
4
RFC
Russell Frank Company
Washington
-$1.9M
5
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
California
-$1.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Systematic Financial Management
New Jersey
$2.55M +$186K +23,375 +9%
PP
27
PDT Partners
New York
$2.47M +$379K +47,601 +21%
Norges Bank
28
Norges Bank
Norway
$2.4M – – –
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$2.33M – – –
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$2.27M -$523K -65,658 -20%
BA
31
BlackRock Advisors
Delaware
$2.26M +$87.4K +10,974 +4%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.15M -$186K -23,300 -9%
Invesco
33
Invesco
Georgia
$2.06M +$750K +94,112 +68%
Two Sigma Investments
34
Two Sigma Investments
New York
$1.97M +$256K +32,149 +17%
Citadel Advisors
35
Citadel Advisors
Florida
$1.9M +$747K +93,768 +78%
AQR Capital Management
36
AQR Capital Management
Connecticut
$1.88M +$1.34M +168,509 +386%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.79M +$324K +40,700 +25%
TCIM
38
TIAA CREF Investment Management
New York
$1.73M -$41K -5,143 -3%
RFC
39
Russell Frank Company
Washington
$1.72M -$1.9M -238,294 -55%
Goldman Sachs
40
Goldman Sachs
New York
$1.54M -$16.8K -2,108 -1%
BCM
41
Bridgeway Capital Management
Texas
$1.48M – – –
BIM
42
BlackRock Investment Management
Delaware
$1.41M +$13.4K +1,682 +1%
GC
43
Globeflex Capital
California
$1.33M +$24 +3 +0%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$1.29M -$157K -19,663 -12%
Federated Hermes
45
Federated Hermes
Pennsylvania
$1.28M +$146K +18,280 +14%
CS
46
Credit Suisse
Switzerland
$1.27M -$215K -27,012 -16%
CCM
47
Cadence Capital Management
Massachusetts
$1.09M -$125K -15,670 -11%
PPA
48
Parametric Portfolio Associates
Washington
$1.08M +$120K +15,004 +14%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.06M -$422K -53,032 -31%
RIM
50
Ranger Investment Management
Texas
$1.06M +$184K +23,050 +24%
1
2
3 4 5

SCLN Hedge Fund Activity: Q1 2015 in Review

130 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q1 2015, worth a combined $316M — down 52% from $652M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of SCLN and 16 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 54 added.

The largest buyer was Franklin Resources, adding an estimated $2.47M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $351M sold.

  • 130 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q1 2015, down from 131 in Q4 2014.
  • Funds reported $316M of Sciclone Pharmaceuticals Inc stock for Q1 2015, down 52% quarter-over-quarter.
  • 16 funds opened new Sciclone Pharmaceuticals Inc positions in Q1 2015 and 17 closed out, a net change of -1 holder.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q1 2015 was Franklin Resources, an estimated $2.47M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q1 2015 was Americafirst Capital Management, an estimated $351M sold.

Based on aggregated 13F filings for Q1 2015.